Svehlikova, E; Regittnig, W; Gatschelhofer, C; Höller, V; Fluhr, G; Lackner, B; Magnes, C; Eberl, A; Pieber, TR.
Dapagliflozin reduces endogenous glucose production during a period of acute insulin deprivation and development of ketoacidosis in people with type 1 diabetes
DIABETOLOGIA. 2024; 67: S128-S129.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN.
[Oral Communication]
Web of Science